Andy Redfern is Associate Professor of Medical Oncology at the University of Western Australia, Associate Director for Clinical Strategy at Harry Perkins Institute of Medical Research, and a Consultant Medical Oncologist at the Fiona Stanley Hospital. Beyond a clinical practice treating breast and urological cancers, he is principal investigator for a range of clinical trials across all phases and has a portfolio of translational research initiatives. His research interests centre around growth signalling and mechanisms of chemotherapy and hormone therapy resistance in cancer, cholesterol biosynthesis in cancer, immunotherapy in bladder and other cancers, differentiation and EMT in cancer progression, tumour-stroma interactions, and poor Indigenous cancer outcomes.